{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:46:13Z","timestamp":1747161973778,"version":"3.40.5"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijcard.2016.11.053","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T17:16:56Z","timestamp":1478798216000},"page":"919-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-6138","authenticated-orcid":false,"given":"Marcus Vinicius Leit\u00e3o","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"de F\u00e1tima dos Santos Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Salles","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.11.053_bb0005","first-page":"225","article-title":"Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature","volume":"38","author":"Traube","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00007611-198910000-00025","article-title":"Thyrocardiotoxic embolic syndrome","volume":"82","author":"Haynes","year":"1989","journal-title":"South. Med. J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/ajem.2001.28045","article-title":"Thyrotoxicosis, atrial fibrillation, and a cerebral vascular accident in a young woman","volume":"19","author":"Siegel","year":"2001","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.6088.688","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"2","author":"Staffurth","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5694\/j.1326-5377.1979.tb119428.x","article-title":"Embolism in thyrotoxic atrial fibrillation","volume":"1","author":"Yuen","year":"1979","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MAJ.0b013e3181adb4c4","article-title":"Thyrotoxicosis causing arterial and venous thrombosis","volume":"338","author":"Lodha","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0035","first-page":"981","article-title":"Angiology occult thyrotoxicosis in patients with atrial fibrillation and an acute arterial embolism","volume":"39","author":"Monreal","year":"1988"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinte.1981.00340090087019","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"141","author":"Bar-Sela","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1445-5994.1981.tb03519.x","article-title":"Atrial fibrillation and arterial embolism in hyperthyroidism","volume":"11","author":"Hurley","year":"1981","journal-title":"Aust. NZ J. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.19.1.15","article-title":"Stroke in thyrotoxicosis with atrial fibrillation","volume":"19","author":"Petersen","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2265.2011.04232.x","article-title":"Atrial fibrillation and hyperthyroidism: relation between transoesophageal markers of a thrombogenic milieu and clinical risk factors for thromboembolism","volume":"76","author":"Souza","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"2003","key":"10.1016\/j.ijcard.2016.11.053_bb0065","first-page":"1146","volume":"108","author":"Cheitlin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.75.1.175","article-title":"Color Doppler assessment of mitral regurgitation with orthogonal planes","volume":"75","author":"Helmcke","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0075","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0735-1097(94)00456-Z","article-title":"Cardiac index quantification by Doppler ultrasound in patients without left ventricular outflow tract abnormalities","volume":"25","author":"Evangelista","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9149(90)90711-9","article-title":"Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava","volume":"66","author":"Kircher","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0085","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.126.1_suppl.7S","article-title":"Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Rubin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0090","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-128-8-199804150-00005","article-title":"Transesophageal echocardiographic correlates of thromboembolism in high risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography","volume":"128","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0735-1097(94)90644-0","article-title":"Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo","volume":"23","author":"Fatkin","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0105","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2169\/internalmedicine.49.3580","article-title":"Significant impairment of left atrial function in patients with cardioembolic stroke caused by paroxysmal atrial fibrillation","volume":"49","author":"Taguchi","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/ejechocard\/jeq045","article-title":"Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC) European Association of Echocardiography","volume":"11","author":"Pepi","year":"2010","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0120","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0125","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/heartjnl-2013-305017","article-title":"Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study TIARA investigators","volume":"100","author":"Dinh","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/heart.89.2.165","article-title":"Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism","volume":"89","author":"Illien","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.echo.2012.11.002","article-title":"Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation","volume":"26","author":"Willens","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","article-title":"Cardiovascular involvement in patients with different causes of hyperthyroidism","volume":"6","author":"Biondi","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0150","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European heart rhythm association; European Association for Cardio-Thoracic Surgery","volume":"31","author":"Camm","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hrthm.2008.10.023","article-title":"Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism","volume":"6","author":"Siu","year":"2009","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/clc.22427","article-title":"Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation","volume":"38","author":"Chan","year":"2015","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0165","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/oxfordjournals.eurheartj.a060524","article-title":"Patent foramen ovale, atrial septal aneurysm and ischaemic stroke in young adults","volume":"15","author":"Mas","year":"1994","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0175","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","article-title":"Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study","volume":"47","author":"Meissner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0185","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.109.192272","volume":"119","author":"O'Gara","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0190","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Patent Foramen Ovale in Cryptogenic Stroke Study (PICSS) investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0195","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0200","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MAJ.0b013e31821790f4","article-title":"Hyperthyroidism and pulmonary hypertension: an important association","volume":"342","author":"Vallabhajosula","year":"2011","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0210","first-page":"93","article-title":"Pulmonary hypertension in thyroid diseases","volume":"55","author":"Scicchitano","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0215","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00380-014-0518-3","article-title":"Autoimmunity and pulmonary hypertension in patients with Graves' disease","volume":"30","author":"Sugiura","year":"2015","journal-title":"Heart Vessel."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0220","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1183\/09031936.05.00045705","article-title":"Autoimmunity and pulmonary hypertension: a perspective","volume":"26","author":"Nicolls","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0225","first-page":"5671","article-title":"Dynamic blood flow and wall shear stress in pulmonary hypertensive disease","volume":"2014","author":"Postles","year":"2014","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0230","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00115.2014","article-title":"Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension","volume":"307","author":"Song","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0235","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.RES.0000130784.90237.4a","article-title":"Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface","volume":"94","author":"Davis","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0240","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0245","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00296-003-0291-6","article-title":"Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency","volume":"23","author":"Nakayama","year":"2003","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0250","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-011-9436-7","article-title":"Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease","volume":"39","author":"Gu","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0255","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/en.2014-1813","article-title":"Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy","volume":"156","author":"Holthoff","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1996.tb02068.x","article-title":"Cardiomyopathy associated with Graves' disease","volume":"45","author":"Koshiyama","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0265","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2009.07.015","article-title":"Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism","volume":"54","author":"Stavrakis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.053_bb0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0034-1370920","article-title":"Relationship between autoantibody to the angiotensin II-1 receptor and cardiovascular manifestations of Graves' disease","volume":"122","author":"Xu","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ijcard.2016.11.053_bb0275","first-page":"168","article-title":"Echocardiographic reference values in a sample of asymptomatic adult Brazilian population","volume":"89","author":"Angelo","year":"2007","journal-title":"Arq. Bras. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731633501X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731633501X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T07:04:25Z","timestamp":1601190265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731633501X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":55,"alternative-id":["S016752731633501X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.053","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}